aTyr Pharma
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $190 |
Gross Profit | -394 | -394 | -21,940 | |
EBITDA | -8,996 | -10,397 | -13,570 | -25,581 |
EBIT | -10,309 | -10,791 | -13,964 | -25,746 |
Net Income | -10,309 | -10,791 | -13,963 | -25,744 |
Net Change In Cash | 0 | 0 | 0 | 190 |
Free Cash Flow | -9,424 | -12,655 | -12,227 | -20,513 |
Cash | 16,160 | 10,008 | 10,743 | 6,150 |
Basic Shares | 98,069 | 98,043 | 98,010 | 97,153 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $190 | $235 | $353 | $10,386 |
Gross Profit | -1,363 | 235 | 353 | 8,691 |
EBITDA | -72,565 | -62,482 | -47,656 | -43,648 |
EBIT | -74,118 | -64,022 | -50,397 | -45,343 |
Net Income | -74,118 | -64,023 | -50,389 | -45,338 |
Net Change In Cash | 190 | 235 | 353 | 10,386 |
Free Cash Flow | -62,063 | -69,184 | -37,436 | -43,527 |
Cash | 10,743 | 11,055 | 22,544 | 9,981 |
Basic Shares | 92,985 | 74,261 | 53,606 | 28,419 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.11 |
2026-03-31 | -$0.11 |
2025-12-31 | -$0.14 |
2025-09-30 | -$0.26 |